Puma Biotechnology
PBYI
PBYI
93 hedge funds and large institutions have $158M invested in Puma Biotechnology in 2024 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 27 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more funds holding
Funds holding: 82 → 93 (+11)
4.97% more ownership
Funds ownership: 56.73% → 61.7% (+5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
93
Holding in Top 10
1
Calls
$4.64M
Puts
$211K
Top Buyers
| 1 | +$14.9M | |
| 2 | +$1.77M | |
| 3 | +$1.65M | |
| 4 |
Jane Street
New York
|
+$1.55M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.4M |
Top Sellers
| 1 | -$6.12M | |
| 2 | -$2.84M | |
| 3 | -$1.65M | |
| 4 |
EP
Eversept Partners
New York
|
-$1.42M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$1.01M |